MoneyWorks4Me

USFDA completes inspection at Alembic Pharma’s Solid Oral Oncology facility at Panelav

28 Jun 2019 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' Solid Oral Oncology facility located at Panelav from June 24, 2019 to June 28, 2019. This was a first scheduled inspection and company passed the inspection without any Form 483 Observation.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..